Product Categories
| Country: | China |
|---|---|
| Tel: | 0371-0371-85513397 |
| Mobile: | +86-18610099868 |
| E-mail: | info@granlen.com |
| QQ: | 1726136326 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Vericiguat D3 | Details |
| (4R)-4-((3S,5R,8R,10S,12R,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | C24H40O4 | 84848-09-9 | Details |
| Picolinic acid hydrochloride | C6H6ClNO2 | 636-80-6 | Details |
| Olaparib | C24H23FN4O3 | 763113-22-0 | Details |
| Ruxolitinib | C17H18N6 | 941678-49-5 | Details |
| Osimertinib | C28H33N7O2 | 1421373-65-0 | Details |
| 1-Naphthol | C10H8O | 90-15-3 | Details |
| Methocarbamol-d3 | C11H15NO5 | 1346600-86-9 | Details |
| 5-Cyano-2-picoline | C7H6N2 | 3222-48-8 | Details |
| Lorlatinib | C12H13N5O4 | 1191237-69-0 | Details |
| 4-Cyanopyridine | C6H4N2 | 100-48-1 | Details |
| methyl (4R)-4-((3S,5R,8R,10S,12R,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | C25H42O4 | 81702-91-2 | Details |
| Lenvatinib | C21H19ClN4O4 | 417716-92-8 | Details |
| Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
| 4-Picolinic acid | C6H5NO2 | 55-22-1 | Details |
| α-Methylcinnamaldehyde | C10H10O | 101-39-3 | Details |
| Vimseltinib | C23H25N7O2 | 1628606-05-2 | Details |
| Treosulfan | C6H14O8S2 | 299-75-2 | Details |
| (4R)-4-((3R,5R,8R,10S,12S,13R,14S,17R)-12-hydroxy-3-methoxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | C25H42O4 | 146945-48-4 | Details |
| methyl (R)-4-((3R,5R,8S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | C25H40O3 | 108750-62-5 | Details |
| 2-amino-5-chlorobenzene-1,3-disulfonamide | C6H8ClN3O4S2 | 859916-07-7 | Details |
| 4-amino-5-chlorobenzene-1,3-disulfonyl dichloride | C6H4Cl3NO4S2 | 30556-81-1 | Details |
| Tezacaftor | C26H27F3N2O6 | 1152311-62-0 | Details |
| Acalabrutinib | C26H23N7O2 | 1420477-60-6 | Details |
| (4R)-4-((3R,5R,8R,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | C24H40O3 | 434-13-9 | Details |
| 6-Methylnicotinic acid | C7H7NO2 | 3222-47-7 | Details |
| Epalrestat Impurity | C17H17NO3S2 | 682775-71-9 | Details |
| (4R)-4-((3S,5R,8R,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | C24H38O4 | 4560-58-1 | Details |
| Pomalidomide | C13H11N3O4 | 19171-19-8 | Details |
| Amifostine Thiol Dihydrochloride | C5H14N2S | 14653-77-1 | Details |
| Ivacaftor | C24H28N2O3 | 873054-44-5 | Details |
| Trametinib | C26H23FIN5O4 | 871700-17-3 | Details |
| Vilanterol Trifenatate | C44H49Cl2NO7 | 503070-58-4 | Details |
| Dabrafenib | C23H20F3N5O2S2 | 1195765-45-7 | Details |
| Ribociclib | C23H30N8O | 1211441-98-3 | Details |
| (S)-5-amino-3,4-dihydro-2H-pyrrole-2-carboxylic acid hydrochloride | C5H9ClN2O2 | 110971-81-8 | Details |
| Lenalidomide | C13H13N3O3 | 191732-72-6 | Details |
| S)-3-Dimethylamino-3-phenylpropanol | C11H17NO | 82769-75-3 | Details |
| (4R)-4-((3R,5R,8R,10S,12R,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | C24H40O4 | 570-62-7 | Details |
| Suzetrigine | C21H20F5N3O4 | 2649467-58-1 | Details |
| 2-amino-5-chlorobenzene-1,3-disulfonic acid | C6H4Cl3NO4S2 | 89598-89-0 | Details |
| Mirdametinib | C16H14F3IN2O4 | 391210-10-9 | Details |
| resmetirom | C17H12Cl2N6O4 | 920509-32-6 | Details |
| inavolisib | C18H19F2N5O4 | 2060571-02-8 | Details |
| Rhodanine-3-acetic acid | C5H5NO3S2 | 5718-83-2 | Details |
| 2-Fluoronaphthalene | C10H7F | 323-09-1 | Details |
| Dotinurad | C14H9Cl2NO4S | 1285572-51-1 | Details |
| revumenib | C32H47FN6O4S | 2169919-21-3 | Details |
| 6-Hydroxynicotinic acid | C6H5NO3 | 5006-66-6 | Details |
| Apixaban | C25H25N5O4 | 503612-47-3 | Details |
| Fluticasone furoate | C27H29F3O6S | 397864-44-7 | Details |
| Empagliflozin | C23H27ClO7 | 864070-44-0 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| Tafamidis Meglumine | C21H24Cl2N2O8 | 951395-08-7 | Details |
| 2,5-Dihydroxybenzoic acid | C7H6O4 | 490-79-9 | Details |
| 4-amino-5-chlorobenzene-1,3-disulfonamide | C6H8ClN3O4S2 | 1083-36-9 | Details |
| 2,5-Pyridinedicarboxylic acid | C7H5NO4 | 100-26-5 | Details |
| Enzalutamide | C21H16F4N4O2S | 915087-33-1 | Details |
| Alectinib | C30H34N4O2 | 1256580-46-7 | Details |
| Dolutegravir | C20H19F2N3O5 | 1051375-16-6 | Details |
| Venetoclax | C45H50ClN7O7S | 1257044-40-8 | Details |
| Dapagliflozin | C24H33ClO8 | 960404-48-2 | Details |
| Bictegravir | C21H18F3N3O5 | 1611493-60-7 | Details |
| Taletrectinib | C29H34FN5O5 | 1505515-69-4 | Details |
| Pyridine-2,5-dicarbonitrile | C7H3N3 | 20730-07-8 | Details |
| methyl (4R)-4-((3R,5R,8R,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | C25H42O3 | 1249-75-8 | Details |
| Nintedanib | C31H33N5O4 | 656247-17-5 | Details |
| Abemaciclib | C27H32F2N8 | 1231929-97-7 | Details |
| Edoxaban tosylate | C24H30ClN7O4S.C7H8O3S | 480449-71-6 | Details |
| Ensartinib | C25H25Cl2FN6O3 | 1365267-27-1 | Details |
| Sacubitril mixture with valsartan | C48H58N6O8 | 936623-90-4 | Details |
| 2,2'-Bipyridine-5,5'-dicarboxylic acid | C12H8N2O4 | 1802-30-8 | Details |
| (4R)-4-((3S,5R,8R,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | C24H40O4 | 570-63-8 | Details |
| methyl (4R)-4-((3S,5R,8R,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | C25H42O4 | 28050-36-4 | Details |
| 1-Fluoronaphthalene | C10H7F | 321-38-0 | Details |
| Baricitinib | C16H17N7O2S | 1187594-09-7 | Details |
| Avutometinib | C21H18FN5O5S | 946128-88-7 | Details |
| Defactinib | C20H21F3N8O3S | 1073154-85-4 | Details |
| lazertinib | C30H34N8O3 | 1903008-80-9 | Details |
| methyl (4R)-4-((3R,5R,8R,10S,12R,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | C25H42O4 | 80225-61-2 | Details |
| vorasidenib | C14H13ClF6N6 | 1644545-52-7 | Details |
| 3-Aminosalicylic acid | C7H7NO3 | 570-23-0 | Details |
| apalutamide | C21H15F4N5O2S | 956104-40-8 | Details |
| Umeclidinium bromide | C29H34BrNO2 | 869113-09-7 | Details |
| methyl (4R)-4-((3S,5R,8R,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-12-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | C25H40O4 | 18069-51-7 | Details |
| Picolinonitrile | C6H4N2 | 100-70-9 | Details |
| zanubrutinib | C27H29N5O3 | 1691249-45-2 | Details |
| Elexacaftor | C26H34F3N7O4S | 2216712-66-0 | Details |
| Nicotinonitrile | C6H4N2 | 100-54-9 | Details |
| (R)-4-((3R,5R,8S,10S,12R,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid | C24H38O4 | 24637-45-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 | ||||